ogotherapy and Death Anxiety

Phase 3

• Conditions: Cancer.; Follow-up examination after treatment for malignant neoplasms

• Registration Number: IRCT2014093017237N5
• Lead Sponsor: Deputy of Research and Technology, Golestan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

No history of physical disabilities before occurring cancer; interested in participating in the research project; no history of psychiatric disorder; no history of crisis such as divorce; death and loss of loved ones during last 6 months.
Exclusion criteria: lack of attending in group logotherapy three times continuous or six sessions interrupted for any reason; immigration; patients who will be discharged or died during the study; cardiopulmonary resuscitation during the study.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Death anxiety. Timepoint: Before intervention and a week after five weeks intervention. Method of measurement: Templer Death Anxiety Scale.

Secondary Outcome Measures

Name	Time	Method
Spirituality. Timepoint: Before intervention and a week after five weeks intervention. Method of measurement: Spirituality Questionnaire.